Methylenetetrahydrofolate reductase C677T and A1298C gene polymorphisms and therapy-related toxicity in children treated for acute lymphoblastic leukemia and non-Hodgkin lymphoma

References

• Reiter A, Schrappe M, Tiemann M, Ludwig W D, Yakisan E, Zimmermann M, et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report from Berlin-Frankfurt-Münster Group Trial NHL-BFM 90. Blood 1999; 94: 3294–3306
   PubMed Web of Science ®Google Scholar
• Schrappe M, Reiter A, Ludwig W D, Harbott J, Zimmermann M, Hiddemann W, et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of antracyclines and cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95: 3310–3322
   PubMed Web of Science ®Google Scholar
• Monahan B P, Allegra C J. Antifolates. Cancer Chemotherapy and Biotherapy: Principles and Practices4th edn, B A Chabner, D L Longo. Lippincott Williams and Wilkins, Philadelphia 2006; 108–113
   Google Scholar
• Rosenblatt D. Clinically important genes: methylentetrahydrofolate reductase. Clin Invest Med 2001; 24: 56–59
   PubMed Web of Science ®Google Scholar
• Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, et al. Gene structure of human and mouse methylenetetrahydrofolate reductase. Mamm Genome 1998; 9: 652–656
   PubMed Web of Science ®Google Scholar
• Krajinovic M, Lamothe S, Labuda D, Lemieux-Blanchard E, Theoret Y, Sinnett D. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004; 103: 252–257
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom H J, Milos R, Goyette P, Sheppard C A, Mathews R G, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111–113
   PubMed Web of Science ®Google Scholar
• Costea I, Moghrabi A, Laverdiere C, Graziani A, Krajinovic M. Folate cycle gene variants and chemotherapy toxicity in pediatric patients with acute lymphoblastic leukemia. Haematologica 2006; 91: 1113–1116
   PubMed Web of Science ®Google Scholar
• Oliveira E, Alves S, Quental S, Ferreira F, Norton L, Costa V, et al. The MTHFR C677T and A1298C polymorphisms and susceptibility to childhood acute lymphoblastic leukemia in Portugal. J Pediatr Hematol Oncol 2005; 27: 425–429
   PubMed Web of Science ®Google Scholar
• Wiemels J L, Smith R N, Taylor G M, Eden O B, Alexander F E, Greaves M F. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001; 98: 4004–4009
   PubMed Web of Science ®Google Scholar
• Alcasabas P, Ravindranath Y, Goyette G, Haller A, del Rosario L, Lesaca-Medina M Y, et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) polymorphisms and the risk of acute lymphoblastic leukemia (ALL) in Philipino children. Pediatr Blood Cancer 2008; 51: 178–182
   PubMed Web of Science ®Google Scholar
• Reddy H, Jamil K. Polimorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphoblastic leukemia in an Indian population. Leuk Lymphoma 2006; 47: 1333–1339
   PubMed Web of Science ®Google Scholar
• Shimasaki N, Mori T, Samejima H, Sato R, Shimada H, Yahagi N, et al. Effects of methylenetetrahydrofolate reductase and reduced folate carrier 1 polymorphisms on high-dose methotrexate-induced toxicities in children with acute lymphoblastic leukemia or lymphoma. J Pediatr Hematol Oncol 2006; 28: 64–68
   PubMed Web of Science ®Google Scholar
• Gemmati D, Ongaro A, Tognazzo S, Catozzi L, Federici F, Mauro E, et al. Methylenetetrahydrofolate reductase C677T and A1298C gene variants in adult non-Hodgkin's lymphoma patients: association with toxicity and survival. Haematologica 2007; 92: 478–485
   PubMed Web of Science ®Google Scholar
• Imanishi H, Okamura N, Yagi M, Noro Y, Moriya Y, Nakamura T, et al. Genetic polymorphisms associated with adverse events and elimination of methotrexate in childhood acute lymphoblastic leukemia and malignant lymphoma. J Hum Genet 2007; 52: 166–171
   PubMed Web of Science ®Google Scholar
• Ruiz-Argüelles G J, Coconi-Linares L N, Garces-Eisele J, Reyes-Nunez V. Methotrexate-induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico. Hematology 2007; 12: 387–391
   PubMed Web of Science ®Google Scholar
• Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, et al. Effect of methylenetetrahydrofolate reductase 677C → T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 2003; 103: 294–299
   PubMed Web of Science ®Google Scholar
• Aplenc R, Thompson J, Han P, La M, Zhao H, Lange B, et al. Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia. Cancer Res 2005; 65: 2482–2487
   PubMed Web of Science ®Google Scholar
• Ulrich C M, Yasui Y, Storb R, Schubert M M, Wagner J L, Bigler J, et al. Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001; 98: 231–234
   PubMed Web of Science ®Google Scholar
• Chiusolo P, Reddiconto G, Farina G, Mannocci A, Fiorini A, Palladino M, et al. MTHFR polymorphisms' influence on outcome and toxicity in acute lymphoblastic leukemia patients. Leuk Res 2007; 31: 1669–1674
   PubMed Web of Science ®Google Scholar
• Seidemann K, Book M, Zimmermann M, Meyer U, Welte K, Stanulla M, et al. MTHFR 677 (C → T) polymorphism is not relevant for prognosis or therapy-associated toxicity in pediatric NHL: results from 484 patients of multicenter trial NHL-BFM 95. Ann Hematol 2006; 85: 291–300
   PubMed Web of Science ®Google Scholar
• Aslanidis C, Schmitz G. High-speed methylenetetrahydrofolate reductase C→T 677 mutation detection on the lightCycler. Rapid Cycle Real-Time PCR: Methods and Applications, S Meuer, C Wittwer, K Nakagawara. Springer-Verlag, Berlin, Heidelberg 2001; 83–89
   Google Scholar
• Bagley P J, Selhub J. A common mutation in the methylenetetrahydrofolate reductase gene is associated with an accumulation of formylated tetrahydrofolates in red blood cells. Proc Natl Acad Sci USA 1998; 95: 13217–13220
   PubMed Web of Science ®Google Scholar
• Davis S R, Quinlivan E P, Shelnutt K P, Maneval D R, Ghandour H, Capdevila A, et al. The methylenetetrahydrofolate reductase 677C → T polymorphism and dietary folate restriction affect plasma one-carbon metabolites and red blood cell folate concentrations and distribution in women. J Nutr 2005; 135: 1040–1044
   PubMed Web of Science ®Google Scholar
• Relling M V, Fairclough D, Ayers D. Patient characteristics associated with high-risk methotrexate concentrations and toxicity. J Clin Oncol 1994; 12: 1667–1672
   PubMed Web of Science ®Google Scholar
• Joannon P, Oviedo I, Campbell M, Tordecilla J. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance. Pediatr Blood Cancer 2004; 43: 17–22
   PubMed Web of Science ®Google Scholar
• Sazci A, Ergul E, Kaya G, Kara I. Gnotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 2005; 23: 51–54
   PubMed Web of Science ®Google Scholar
• Rady P, Szucs S, Grady J, Hudnall S D, Kellner L H, Nitowsky H, et al. Genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) in ethnic populations in Texas: a report of a novel MTHFR polymorphic site, G1793A. Am J Med Genet 2002; 107: 162–168
   PubMed Web of Science ®Google Scholar
• Balta G, Yuksek N, Ozyurek E, Ertem U, Hicsonmez G, Altay C, et al. Characterization of MTHFR, GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes in childhood acute leukemia. Am J Hematol 2003; 73: 154–160
   PubMed Web of Science ®Google Scholar